Skip to main content
VA Rating Assistant

DC 6819 · 38 CFR 4.97

Lung Cancer (Malignant Respiratory Neoplasm) C&P Exam Prep

To document the current status, treatment history, residuals, and functional impact of a malignant respiratory neoplasm (lung cancer) for VA disability rating purposes under DC 6819. Active malignancy is rated 100%; after treatment ends, a mandatory re-examination at six months post-treatment determines the ongoing rating based on residuals.

Format:
Interview + Physical
Typical duration:
20-45 minutes
DBQ form:
Respiratory_Conditions_Other_than_Tuberculosis_and_Sleep_Apnea (Respiratory_Conditions_Other_than_Tuberculosis_and_Sleep_Apnea)
Examiner:
Pulmonologist or Physician

What the examiner evaluates

  • Confirmation and documentation of the lung cancer diagnosis, ICD code, date of diagnosis, and whether primary or metastatic
  • Current treatment status: surgery, radiation therapy, antineoplastic chemotherapy, immunotherapy, or other therapeutic procedures
  • Date of treatment completion or anticipated completion date
  • Presence of local recurrence or distant metastasis
  • Pulmonary function testing results (FVC, FEV1, FEV1/FVC ratio, DLCO) with pre- and post-bronchodilator values
  • Systemic symptoms: weight loss, anorexia, hemoptysis, night sweats, fever, fatigue
  • Physical examination findings: scattered rales, limitation of diaphragm excursion, pain or discomfort on exertion, cor pulmonale, right ventricular hypertrophy, pulmonary hypertension
  • Imaging results: chest X-ray, CT scan, MRI, PET scan with dates and findings
  • Biopsy and bronchoscopy results
  • Tumor characteristics: location, size measurements (length x width in cm), primary vs. secondary/metastatic designation
  • Residual conditions following treatment completion
  • Any complications such as pleural effusion, pneumothorax, respiratory failure, cardiopulmonary complications
  • Need for supplemental outpatient oxygen therapy
  • Episodes of acute respiratory failure
  • Functional impact on occupational and daily activities
  • Whether condition is in active treatment, remission, or resolved

Exam may be conducted in person or via telehealth. Bring all oncology records, imaging reports, pathology/biopsy reports, operative reports, and treatment summaries. If post-treatment, bring documentation of treatment completion dates. The examiner will review your claims file (C-file) and may order or review pulmonary function tests. Confirm ahead of time whether PFTs will be performed at the exam or if prior results will be used.

Measurements and tests

Spirometry - FVC (Forced Vital Capacity)

What it measures: The total amount of air you can forcefully exhale after a full breath; reflects restrictive or obstructive lung disease patterns and is used to rate respiratory disability after cancer treatment ends.

What to expect: You will be asked to breathe in as deeply as possible, then exhale as hard and fast as you can into a mouthpiece connected to a spirometer. The test is repeated at least three times. Post-bronchodilator testing may follow.

Critical thresholds

  • FVC > 80% predicted No pulmonary impairment - would support lower residuals rating (0-10%) if cancer resolved
  • FVC 65-80% predicted Mild restriction - supports 30% residuals rating
  • FVC 50-64% predicted Moderate restriction - supports 60% residuals rating
  • FVC < 50% predicted Severe restriction - supports 100% residuals rating

Tips

  • Perform your best effort on every attempt - hold nothing back, as submaximal effort produces lower numbers that underrepresent your true impairment
  • Do not use short-acting bronchodilators (albuterol) within 4 hours of the test unless medically necessary
  • Bring any prior PFT results from your oncologist or pulmonologist so the examiner can compare trends
  • Report any chest pain, shortness of breath, or dizziness during the test immediately to the technician

Pain considerations: If you experience chest pain, chest wall discomfort, or post-surgical pain that limits your ability to take a full breath or exhale forcefully, tell the technician before and during testing. Surgical resection (lobectomy, pneumonectomy) significantly reduces lung volume and will affect results.

Spirometry - FEV1 (Forced Expiratory Volume in 1 Second)

What it measures: The volume of air exhaled in the first second of a forced breath; the primary metric used to rate COPD and obstructive patterns that may coexist with or result from lung cancer or its treatment.

What to expect: Measured simultaneously with FVC during spirometry. The ratio of FEV1/FVC helps distinguish obstructive vs. restrictive patterns. Both pre- and post-bronchodilator values are typically recorded.

Critical thresholds

  • FEV1 > 80% predicted No significant obstruction - supports lower residuals rating
  • FEV1 71-80% predicted Mild obstruction - supports 30% rating on obstructive pattern
  • FEV1 56-70% predicted Moderate obstruction - supports 60% rating
  • FEV1 40-55% predicted Moderately severe - supports 60% rating
  • FEV1 < 40% predicted Severe obstruction - supports 100% rating on residuals

Tips

  • Report any wheezing, bronchospasm, or difficulty breathing after inhalation of bronchodilator
  • If you use daily inhalers (bronchodilators or corticosteroids), list all of them to the examiner - these are captured on the DBQ
  • If post-pneumonectomy, FEV1 will be markedly reduced and should be compared against post-surgical predicted values

Pain considerations: Post-thoracotomy or post-VATS pain can cause splinting (guarding the chest wall), which artificially reduces FEV1 and FVC. Inform the examiner if pain is limiting your respiratory effort.

DLCO (Diffusing Capacity of the Lungs for Carbon Monoxide)

What it measures: How effectively oxygen crosses from the air sacs into the bloodstream; reduced in conditions that damage alveolar tissue, including post-radiation fibrosis, surgical resection, or chemotherapy-induced lung damage.

What to expect: You inhale a small amount of carbon monoxide mixed with other gases, hold your breath for about 10 seconds, then exhale. The difference in gas concentration measures gas transfer efficiency. Usually done after spirometry.

Critical thresholds

  • DLCO > 70% predicted Normal to mildly reduced - less supportive of higher residuals ratings
  • DLCO 56-70% predicted Moderate reduction - relevant to 60% residuals consideration
  • DLCO < 40% predicted Severely reduced - supports 100% residuals rating

Tips

  • Do not smoke for at least 24 hours before the test
  • Do not exercise heavily before the test
  • Inform the technician of any recent blood transfusion or hemoglobin changes, which affect results

Pain considerations: If radiation pneumonitis or post-radiation fibrosis is present, DLCO is often more impaired than FEV1 or FVC alone. Be sure to mention any history of radiation therapy to the chest and any onset of new shortness of breath after radiation.

Exercise Capacity / Oxygen Saturation Testing

What it measures: Functional exercise tolerance and oxygen saturation during exertion; used to document desaturation, dyspnea on exertion, and the need for supplemental oxygen therapy.

What to expect: May involve a six-minute walk test or pulse oximetry at rest and with exertion. If you require home oxygen therapy, this will be documented separately on the DBQ.

Critical thresholds

  • SpO2 < 88% on exertion Supports need for supplemental oxygen, relevant to 100% rating
  • MET level < 5 Significantly reduced exercise capacity supporting higher disability rating

Tips

  • If you currently use home oxygen, bring the prescription and equipment specifications
  • Accurately report at what activity level (e.g., walking 50 feet, climbing one flight of stairs) you become short of breath
  • Do not downplay exertional limitations - report your typical worst-day functional capacity

Pain considerations: Chest wall pain, pleuritic pain, or post-surgical pain that limits exertion should be explicitly reported to the examiner and linked to your lung cancer diagnosis or its treatment.

Rating criteria by percentage

100%

Active malignant respiratory neoplasm (lung cancer) under DC 6819. A rating of 100% is assigned for any active malignant neoplasm of the respiratory system. This rating continues beyond the cessation of surgical treatment, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after treatment discontinuance, a mandatory VA examination is required to determine the appropriate ongoing rating based on residuals. Any rating change based on that or subsequent examinations is subject to 38 CFR 3.105(e) (rating reduction protections).

Key symptoms

  • Active cancer diagnosis - primary or metastatic malignancy confirmed by pathology/biopsy
  • Currently undergoing or recently completed surgery, chemotherapy, radiation, immunotherapy, or targeted therapy
  • Local recurrence or distant metastasis present
  • Hemoptysis (frank or massive)
  • Significant weight loss with documented baseline and current weight
  • Anorexia
  • Fever and night sweats
  • Progressive pulmonary disease
  • Respiratory failure requiring hospitalization
  • Cor pulmonale or right ventricular hypertrophy
  • Pulmonary hypertension documented by echocardiogram or cardiac catheterization
  • Requirement for outpatient oxygen therapy

From 38 CFR: 38 CFR 4.97, DC 6819: 'Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths - 100. Note: A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.'

100%

Post-treatment residuals - severe pulmonary impairment. After the mandatory six-month post-treatment examination, if residuals are severe (FVC or FEV1 less than 50% predicted, or DLCO less than 40% predicted, or requirement for continuous oxygen, or documented cor pulmonale or pulmonary hypertension), a 100% rating on residuals may continue. Rating is determined by the degree of functional impairment remaining after active cancer treatment ends.

Key symptoms

  • FVC < 50% predicted on post-bronchodilator testing
  • FEV1 < 40% predicted on post-bronchodilator testing
  • DLCO severely reduced (< 40% predicted)
  • Requirement for continuous home oxygen therapy
  • Cor pulmonale or right heart failure
  • Post-pneumonectomy with severe restrictive pattern
  • Recurrence or metastasis identified at six-month mandatory exam
  • Severe dyspnea limiting activities of daily living to bed or chair rest

From 38 CFR: After six months post-treatment, the rating is determined by the degree of residual impairment. Severe pulmonary function test results, continued oxygen dependency, or cancer recurrence would maintain or restore the 100% rating.

60%

Post-treatment residuals - moderate to moderately severe pulmonary impairment. Applies after the mandatory six-month post-treatment examination when residuals show FVC or FEV1 between 50-70% predicted, or FEV1/FVC ratio reduced with significant functional limitation. Rated analogously under DC 6600 (COPD) or DC 6844 (interstitial lung disease) depending on the pattern of residual impairment.

Key symptoms

  • FEV1 40-70% predicted after treatment
  • FVC 50-69% predicted
  • Dyspnea with moderate exertion (walking on level ground, minimal activity)
  • Productive cough - daily or near-constant
  • Purulent sputum at times
  • Scattered rales on auscultation
  • Some limitation of diaphragmatic excursion
  • Requirement for inhalational bronchodilator therapy
  • Post-radiation fibrosis with reduced DLCO

From 38 CFR: Rated analogously after cancer treatment ends; moderate restriction (FVC 50-64%) or moderate obstruction (FEV1 56-70%) with significant daily functional limitation supports a 60% rating on residuals.

30%

Post-treatment residuals - mild pulmonary impairment. Applies after the mandatory six-month post-treatment examination when residuals are mild; FVC 65-80% predicted or FEV1 71-80% predicted with intermittent symptoms managed with occasional bronchodilators or other medications.

Key symptoms

  • FEV1 71-80% predicted
  • FVC 65-80% predicted
  • Dyspnea on more than ordinary exertion
  • Intermittent productive cough
  • Occasional use of inhalational bronchodilators
  • Mild limitation of activities
  • No acute respiratory failure episodes

From 38 CFR: Mild pulmonary function impairment post-treatment supports a 30% rating on residuals under an analogous respiratory diagnostic code (e.g., DC 6600 or DC 6844).

10%

Post-treatment residuals - minimal pulmonary impairment or asymptomatic with normal pulmonary function tests. Applies after the mandatory six-month post-treatment examination when the veteran has minimal or no measurable residual pulmonary function impairment but may have mild persistent symptoms.

Key symptoms

  • FVC and FEV1 both > 80% predicted
  • Essentially normal spirometry post-treatment
  • Occasional mild dyspnea
  • Minimal productive cough
  • No requirement for bronchodilators or oxygen

From 38 CFR: Minimal residuals after cancer treatment with essentially normal or near-normal pulmonary function would support a 10% rating on residuals under an analogous code.

Describing your symptoms accurately

Dyspnea (Shortness of Breath)

How to describe it: Describe exactly what activity triggers your shortness of breath and how it limits you. Use specific distances, stair counts, or time durations. Distinguish between rest, mild exertion (dressing, walking to the bathroom), moderate exertion (walking one block, climbing one flight), and strenuous activity. Report your worst-day experience, not your best day.

Example: On my worst days, I become severely short of breath after walking fewer than 50 feet on level ground. I have to stop and rest before continuing. I cannot climb a single flight of stairs without stopping halfway due to air hunger. I need to use my rescue inhaler before any physical activity and still feel winded afterward.

Examiner listens for: Specific activity thresholds, frequency of occurrence, whether dyspnea is progressive (worsening over time), whether it limits work activities, and whether supplemental oxygen is needed.

Avoid: Do not say 'I get a little winded sometimes.' Instead say: 'I am short of breath with minimal exertion, including activities like getting dressed or walking from my bedroom to the kitchen, and this occurs every day.'

Hemoptysis (Coughing Up Blood)

How to describe it: Report whether you cough up blood-tinged sputum occasionally, have frank hemoptysis (bright red blood), or have experienced massive hemoptysis. Note frequency, volume, and any associated emergency care. The DBQ distinguishes between blood-tinged sputum, occasional hemoptysis, frank hemoptysis, and massive hemoptysis - make sure the examiner documents the accurate category.

Example: On my worst episodes, I cough up bright red blood approximately two to three times per week. The amount varies from streaks in my sputum to occasionally coughing up a full tablespoon of blood. I had one episode severe enough that I went to the emergency room.

Examiner listens for: Frequency, volume, acuity (blood-tinged vs. frank vs. massive), need for emergency or hospital care, and relationship to cancer or its treatment.

Avoid: Do not minimize hemoptysis by saying 'just a little blood.' If you have experienced frank hemoptysis, say so clearly and describe how often it occurs.

Constitutional Symptoms (Weight Loss, Anorexia, Fatigue, Night Sweats, Fever)

How to describe it: For weight loss, provide a specific baseline weight before your diagnosis or the onset of symptoms, your current weight, and the time period over which the loss occurred. For fatigue, describe how it limits your ability to work, perform household tasks, or engage in recreational activities. For night sweats, report frequency and severity (e.g., needing to change clothes or bedding).

Example: I have lost 28 pounds over the past eight months, going from 195 lbs to 167 lbs without intentionally dieting. My appetite is poor most days - I can only eat small amounts before feeling full or nauseated. My fatigue is so severe that I spend most of my day resting and cannot complete basic household tasks without needing to lie down afterward. I experience night sweats at least four nights per week that soak through my clothing.

Examiner listens for: Quantified weight loss with documented baseline, the temporal relationship of weight loss to cancer diagnosis and treatment, severity and frequency of fatigue, and whether these symptoms are treatment-related (e.g., chemotherapy side effects) vs. cancer-related.

Avoid: Do not say 'I've lost some weight.' Provide exact numbers. Do not underreport fatigue by only mentioning it in passing - describe its impact on your ability to perform daily activities, work, and social functioning.

Cough (Productive and Non-Productive)

How to describe it: Distinguish between a dry cough and a productive cough with sputum. If productive, describe the color (clear, yellow, green, blood-tinged), consistency, and approximate volume. Report frequency: intermittent, daily, or near-constant. Note whether it wakes you from sleep, affects your ability to speak or eat, or has required antibiotic treatment.

Example: I have a persistent productive cough every day. On bad days, I cough almost continuously throughout the day, producing yellowish-green sputum in significant amounts. The cough wakes me up at night at least three to four times per week. I have required antibiotic treatment twice in the last year for infections related to this cough.

Examiner listens for: Frequency (intermittent vs. daily vs. near-constant), character (productive vs. dry), sputum characteristics, whether antibiotics are required, and whether the cough causes secondary complications like rib pain, vomiting, or sleep disruption.

Avoid: Do not say 'I just have a little cough.' Specify how often you cough, what comes up, and how it affects your daily life and sleep.

Chest Pain and Functional Limitations

How to describe it: Describe any chest pain, chest wall discomfort, or pleuritic pain. Note whether it is at rest or with exertion, its location, severity on a 1-10 scale, and what makes it better or worse. Also describe the overall functional impact of your condition on your ability to work, perform ADLs (activities of daily living), drive, exercise, and maintain social relationships.

Example: On my worst days, I have a constant dull aching pain in my left chest wall where I had surgery, rated 6 out of 10, that worsens to 9 out of 10 with any deep breathing or physical exertion. This pain, combined with my shortness of breath, prevents me from working, lifting anything heavier than a gallon of milk, walking more than a short distance, or participating in activities I previously enjoyed.

Examiner listens for: Specific pain descriptors, relationship to exertion and respiration, impact on occupational and social functioning, and whether the pain is related to surgical resection, tumor invasion, or post-radiation changes.

Avoid: Do not say 'I'm managing.' Report the true impact on your daily function. The examiner is required to document the functional impact of your condition on your occupation and daily activities.

Treatment Side Effects and Complications

How to describe it: Accurately report all side effects from chemotherapy, radiation, surgery, or immunotherapy that continue to affect you. This includes peripheral neuropathy, radiation pneumonitis, post-radiation fibrosis, post-surgical complications, immunotherapy-related lung inflammation, and any hospitalizations resulting from treatment complications.

Example: Since completing chemotherapy, I experience persistent nausea, profound fatigue, and decreased exercise tolerance that has not returned to pre-treatment levels. My radiation treatments caused radiation pneumonitis that was treated with steroids and has left me with reduced lung capacity. I was hospitalized once during treatment for a respiratory complication requiring oxygen therapy.

Examiner listens for: Specific treatment-related complications, whether they are resolved or ongoing, hospitalization dates and reasons, whether they have resulted in permanent residual conditions, and the cumulative functional impact of the cancer and its treatment.

Avoid: Do not omit hospitalizations or ER visits related to your cancer or its treatment. These are directly relevant to the DBQ and support documentation of disease severity.

Common mistakes to avoid

Not bringing complete oncology treatment records to the exam

Why: The DBQ requires specific dates of diagnosis, surgery, chemotherapy start/completion, radiation therapy, and immunotherapy. Without these records, the examiner may document incomplete information, which can lead to an inaccurate rating.

Do this instead: Bring a complete packet including: pathology/biopsy reports, surgical operative reports, chemotherapy treatment summaries with start and end dates, radiation therapy records, most recent oncology visit notes, and all imaging reports (CT, PET scan, MRI, chest X-ray).

Impact: 100% active / post-treatment mandatory re-exam

Not understanding the six-month post-treatment mandatory re-examination rule

Why: Many veterans do not realize that their 100% rating continues for six months after treatment ends, after which VA must schedule a mandatory exam to rate the condition based on residuals. Missing this exam or failing to prepare for it can result in an uninformed rating reduction.

Do this instead: Know the exact date your last treatment ended. Six months later, expect a mandatory VA exam. Prepare a complete residuals summary showing PFT results, ongoing symptoms, functional limitations, and any new complications. If cancer has recurred or metastasized, document that clearly to maintain the 100% rating.

Impact: 100% post-treatment transition

Failing to accurately report the full extent of weight loss

Why: Weight loss is a specific rated symptom on the DBQ and reflects cancer severity and systemic impact. Vague reporting ('I've lost some weight') does not give the examiner what is needed to check the weight loss checkbox and document the baseline vs. current weight fields on the DBQ.

Do this instead: Know your pre-diagnosis or pre-treatment weight (baseline) and your current weight. Bring documentation from medical records if possible. State the exact numbers: 'I weighed 185 lbs before my diagnosis and currently weigh 157 lbs, a loss of 28 lbs over the past ten months.'

Impact: 100% active / residuals rating

Downplaying or minimizing symptoms because 'the cancer is in remission'

Why: Even if cancer is currently in remission, residual effects of the disease and its treatment (surgical resection, radiation fibrosis, chemotherapy-induced lung damage) are ratable and important. Veterans sometimes feel their symptoms 'don't count' after remission, leading to under-documentation.

Do this instead: Report all ongoing symptoms accurately, including those caused by treatment. Residual pulmonary function impairment, persistent fatigue, post-surgical pain, and reduced exercise capacity are all legitimate and ratable. Describe your symptoms as they actually are on your worst days.

Impact: Post-treatment residuals rating (30-100%)

Not disclosing hospitalizations or ER visits related to cancer or treatment

Why: The DBQ specifically asks about episodes of acute respiratory failure, hospitalizations, and complications resulting in hospitalization. Omitting these underrepresents the severity of your condition and may result in a lower rating.

Do this instead: List all hospitalizations and ER visits related to your lung cancer or its treatment, including dates and reasons. Bring discharge summaries if available. Report any episodes of respiratory failure, oxygen dependence, or ICU admission.

Impact: 100% active / residuals rating

Failing to mention the need for supplemental oxygen or breathing medications

Why: The DBQ has a specific field for outpatient oxygen therapy requirement and for inhalational bronchodilator and corticosteroid use. These are significant markers of severity. Veterans who use oxygen at home or take daily pulmonary medications sometimes forget to mention them.

Do this instead: Bring a complete list of all medications, including inhalers, oral steroids, oral bronchodilators, and oxygen prescriptions with liter-flow rates. Tell the examiner if you use oxygen at rest, with exertion, or only at night.

Impact: 100% active and residuals rating

Not reporting how lung cancer and treatment have impacted your ability to work

Why: The DBQ has a specific section on functional impact, and the examiner is required to document how the condition affects occupational and daily activities. Failure to address this leaves a gap that raters may use to assign a lower rating.

Do this instead: Prepare a clear, specific statement about how your condition has affected your ability to work, including any job loss, reduced hours, inability to perform physical tasks, cognitive effects from chemotherapy ('chemo brain'), or inability to tolerate occupational environments with dust, fumes, or physical demands.

Impact: All rating levels and TDIU consideration

Assuming the examiner will automatically connect all related conditions to the lung cancer

Why: Secondary conditions such as pulmonary hypertension, cor pulmonale, COPD, restrictive lung disease, or pleural disease caused by or resulting from lung cancer or its treatment must be explicitly mentioned. The examiner rates what is documented.

Do this instead: Tell the examiner about every respiratory condition that has developed or worsened since your lung cancer diagnosis or treatment. Ask the examiner to document secondary conditions and their relationship to your primary lung cancer claim.

Impact: Residuals rating and secondary condition claims

Prep checklist

  • critical

    Gather all oncology records and treatment documentation

    Collect: pathology/biopsy report confirming diagnosis, operative reports from any lung surgery, chemotherapy treatment summaries with start and completion dates, radiation therapy records with dates and fields treated, immunotherapy or targeted therapy records, all imaging reports (CT scan, PET scan, MRI, chest X-ray) with dates, and most recent oncology and pulmonology visit notes.

    before exam

  • critical

    Obtain and review most recent pulmonary function test results

    Get a copy of your most recent spirometry (FVC, FEV1, FEV1/FVC) and DLCO results from your pulmonologist or oncologist. Know your percent-predicted values. Bring these to the exam in case the examiner references prior results rather than repeating testing.

    before exam

  • critical

    Document your weight history precisely

    Write down your pre-cancer or pre-treatment baseline weight (with approximate date) and your most recent weight. Calculate the total pounds lost. If your medical records document weight over time, bring them or note the dates and weights from appointments.

    before exam

  • critical

    Create a written symptom summary for your worst days

    Write a one-to-two page summary describing your worst-day symptoms: exactly how far you can walk before becoming short of breath, how often you cough, whether you cough up blood, your fatigue level on a scale of 0-10, night sweats frequency, appetite and eating ability, chest pain description, and sleep disruption. This helps ensure you do not forget key information under stress.

    before exam

  • critical

    Compile a complete medication list including inhalers and oxygen

    List all current medications with dosages and frequencies, including: rescue inhalers (albuterol), maintenance inhalers (corticosteroids, LABAs, LAMAs), oral bronchodilators, systemic corticosteroids, chemotherapy agents (if still active), immunotherapy agents, and home oxygen prescription with liter-flow rate and hours per day.

    before exam

  • critical

    List all hospitalizations and ER visits related to lung cancer or treatment

    Compile dates of admission and discharge, reason for hospitalization (e.g., pneumonia, respiratory failure, chemotherapy complications, oxygen requirement), hospital name, and discharge diagnosis. Include any ICU admissions.

    before exam

  • critical

    Know your cancer diagnosis details precisely

    Know the exact histological type of your lung cancer (e.g., non-small cell lung cancer - adenocarcinoma, squamous cell carcinoma, large cell; small cell lung cancer), the date of confirmed diagnosis, the stage at diagnosis (Stage I-IV using TNM staging), and whether it is primary or metastatic. Know the tumor location and size if documented in imaging reports.

    before exam

  • critical

    Understand the PACT Act presumptive eligibility provisions for your cancer

    The PACT Act (August 10, 2022) established presumptive service connection for respiratory cancers in veterans exposed to burn pits, toxic exposures, Agent Orange, radiation, or certain occupational exposures during military service. Review your service history and ensure you have documented any relevant toxic exposure. This affects nexus (service connection), not the rating itself, but is critical to the overall claim.

    before exam

  • recommended

    Prepare a written functional impact statement for work and daily activities

    Write down specifically how your lung cancer and its treatment have affected your ability to: maintain employment, perform your military occupational specialty, do household chores, drive, exercise, care for children or dependents, attend social activities, and sleep. Include any job loss, reduction in hours, inability to perform specific job tasks, or need for work accommodations.

    before exam

  • recommended

    Identify and document all secondary conditions caused by lung cancer or treatment

    List any conditions that have developed or worsened as a result of your lung cancer or treatment: COPD, radiation pneumonitis, pulmonary fibrosis, pleural disease, pulmonary hypertension, cor pulmonale, peripheral neuropathy from chemotherapy, fatigue syndrome, anemia, or immunosuppression-related infections. These may be separately ratable as secondary conditions.

    before exam

  • recommended

    Check your state's exam recording law and bring recording device if permitted

    Many states allow veterans to record their C&P examination. Research your state's one-party or two-party consent requirements. If permitted, bring a smartphone or recording device. Notify the examiner at the start of the exam that you intend to record. This protects your account of what was said during the exam.

    before exam

  • recommended

    Contact your VSO or accredited claims agent for pre-exam counseling

    A Veterans Service Organization (VSO) representative, accredited claims agent, or VA-accredited attorney can review your claim file, identify any evidence gaps, and help you understand what the examiner will focus on. Schedule this meeting at least one to two weeks before your exam.

    before exam

  • critical

    Arrive at your baseline - do not overexert yourself before the exam

    Do not perform strenuous physical activity the day before or the morning of your exam. Come to the exam in the condition that accurately represents your typical daily functional state. If you are having a worse-than-average day due to symptoms, note that explicitly to the examiner.

    day of

  • critical

    Follow spirometry preparation instructions

    If pulmonary function testing will be conducted: avoid short-acting bronchodilators for 4 hours prior (unless medically necessary), avoid smoking for at least 24 hours, avoid heavy meals within 2 hours, wear comfortable loose-fitting clothing, and avoid heavy exercise for 30 minutes before testing.

    day of

  • critical

    Bring your complete document packet

    Bring all medical records, imaging reports, biopsy results, medication list, hospitalization list, symptom summary, and weight history in an organized folder. Bring a copy of your VA rating decision if this is a re-examination or increase claim.

    day of

  • optional

    Bring a trusted support person if needed

    You may bring a family member, caregiver, or VSO representative to the exam for support. Note that their role is typically as an observer, not a participant, unless the examiner invites their input. Their presence can help you remember to report all symptoms.

    day of

  • critical

    Report your worst-day symptoms, not your best-day symptoms

    Per VA M21-1 guidance, veterans should report how their condition affects them on their worst days, not their average or best days. If the examiner asks 'How are you doing today?', clarify: 'Today is not my worst day. On my worst days, I experience...' Then describe your most severe symptom episodes.

    during exam

  • critical

    Confirm the examiner documents your current treatment status accurately

    Verify the examiner understands whether your cancer is: currently active and undergoing treatment (100% rating continues), in active treatment but treatment has not yet completed, in remission with treatment recently completed (triggers 6-month clock), or recurrent/metastatic. This determination drives the entire rating.

    during exam

  • critical

    Explicitly address each symptom category from the DBQ

    Reference the DBQ symptom checklist by mentioning each relevant symptom: productive cough frequency, hemoptysis, weight loss with numbers, anorexia, fatigue, night sweats, fever, dyspnea at rest and with exertion, chest pain, and any secondary complications. Do not wait to be asked - proactively report all symptoms.

    during exam

  • critical

    Describe the functional impact on occupation and daily activities

    The DBQ has a dedicated field for functional impact. Explicitly state: 'This condition prevents me from [specific activity] because [specific reason].' Address your work capacity, ADL limitations, and social functioning. Be specific and quantitative wherever possible.

    during exam

  • critical

    Report all medications and oxygen use

    Verbally confirm all medications listed on your written list and give it to the examiner to include in the DBQ. Specifically mention home oxygen, daily inhalers (bronchodilators and corticosteroids), oral steroids, and any chemotherapy or immunotherapy agents currently active.

    during exam

  • recommended

    Do not be pressured to minimize your symptoms

    If the examiner seems rushed or asks leading questions suggesting your symptoms are mild, calmly and respectfully provide accurate information. You are not required to agree with the examiner's characterization of your symptoms. Your job is to accurately and completely describe your condition.

    during exam

  • critical

    Write a detailed personal account of the exam immediately afterward

    As soon as the exam ends, write down everything you remember: what questions were asked, what your answers were, what the examiner examined, whether PFTs were performed, and whether you felt the exam was thorough or inadequate. Include the examiner's name, specialty, and the date and duration of the exam.

    after exam

  • critical

    Request a copy of the completed DBQ

    You have the right to receive a copy of your completed Disability Benefits Questionnaire. Submit a written request to the VA regional office or the exam contractor (e.g., VES, LHI, Optum Serve) after the exam. Review it for accuracy and completeness.

    after exam

  • recommended

    File a supplemental claim or request CUE if the DBQ is inadequate

    If the examiner failed to address all symptoms, did not perform required testing, provided a brief or conclusory opinion without rationale, or documented inaccurate information, you may challenge the exam's adequacy. Consult with a VSO or accredited attorney about options including requesting a new examination, filing a supplemental claim with additional evidence, or submitting a buddy statement to correct the record.

    after exam

  • critical

    Prepare for the mandatory six-month post-treatment re-examination

    Mark your treatment completion date on your calendar. Six months later, VA is required to schedule a mandatory re-examination under DC 6819. Begin tracking your post-treatment residual symptoms now: PFT results, dyspnea severity, weight stabilization or continued loss, oxygen use, and any new complications. Compile updated medical records for this future exam.

    after exam

  • recommended

    Consider filing for TDIU (Total Disability Individual Unemployability) if applicable

    If your lung cancer and its residuals prevent you from maintaining substantially gainful employment, you may be eligible for TDIU (38 CFR 4.16) even if your schedular rating after treatment ends falls below 100%. Discuss this with your VSO or accredited claims agent at your next appointment.

    after exam

Your rights during a C&P exam

  • You have the right to record your C&P examination in most states - check your state's consent laws and notify the examiner at the start of the appointment.
  • You have the right to receive a copy of the completed Disability Benefits Questionnaire (DBQ) after the exam by requesting it from VA.
  • You have the right to request a new or additional C&P examination if the original exam was inadequate, incomplete, or based on inaccurate information.
  • You have the right to submit buddy statements (VA Form 21-4142 or 21-10210) from family members, caregivers, or fellow veterans who can attest to your symptoms and functional limitations.
  • You have the right to submit a private medical opinion from your own treating physician or a qualified medical expert to support or rebut the VA examiner's findings.
  • You have the right to a mandatory re-examination six months after treatment cessation under DC 6819 - VA is required to conduct this exam before reducing or discontinuing your 100% rating.
  • Under 38 CFR 3.105(e), VA must provide you advance written notice before reducing a disability rating that has been in effect for five or more years, and you have the right to submit evidence and request a hearing before any reduction takes effect.
  • Under the PACT Act (August 10, 2022), veterans with respiratory cancers linked to toxic exposures including burn pits, Agent Orange, radiation, or occupational military exposures may be entitled to presumptive service connection without needing to prove a specific nexus.
  • You have the right to free representation from an accredited Veterans Service Organization (VSO), accredited claims agent, or VA-accredited attorney throughout the claims process.
  • You have the right to appeal any rating decision through the Supplemental Claim lane, the Higher-Level Review lane, or the Board of Veterans' Appeals, and you have one year from the date of the rating decision to select an appeal option.
  • You have the right to request your complete claims file (C-file) from VA to review all evidence of record before and after your examination.
  • If your lung cancer results in an inability to maintain substantially gainful employment, you have the right to file for Total Disability Individual Unemployability (TDIU) under 38 CFR 4.16.

Related conditions

Get a personalized prep packet

This guide covers what to expect for any veteran with this condition. If you have already uploaded your medical records, sign in to generate a packet that maps your specific symptoms to the DBQ fields your examiner will fill out.

Get personalized prep

This C&P exam preparation guide is for educational purposes only and does not constitute legal, medical, or claims advice. Always consult with a qualified Veterans Service Organization (VSO) representative or VA-accredited attorney for guidance specific to your claim. Never exaggerate, minimize, or fabricate symptoms during a C&P examination.